BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 34602462)

  • 1. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
    Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
    Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
    Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
    Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions.
    Wang L; Nie F; Dong T; Yin C; Li M; Li Y
    Clin Hemorheol Microcirc; 2022; 81(2):163-176. PubMed ID: 35253738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
    Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study.
    Zhu HB; Zhu HT; Jiang L; Nie P; Hu J; Tang W; Zhang XY; Li XT; Yao Q; Sun YS
    Eur Radiol; 2024 Jan; 34(1):90-102. PubMed ID: 37552258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
    Kawasaki Y; Hijioka S; Nagashio Y; Maruki Y; Ohba A; Takeshita K; Takasaki T; Agarie D; Hagiwara Y; Hara H; Okamoto K; Yamashige D; Kondo S; Morizane C; Ueno H; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Tamada K; Hiraoka N; Saito Y; Okusaka T
    J Gastroenterol; 2023 Jul; 58(7):693-703. PubMed ID: 37154933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
    Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
    Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Follow-up of Small Nonfunctioning Pancreatic Neuroendocrine Tumors Diagnosed Using Endoscopic Ultrasound-guided Fine-needle Aspiration.
    Takano Y; Yamawaki M; Noda J; Azami T; Niiya F; Maruoka N; Yamagami T; Norose T; Ohike N; Nagahama M
    Intern Med; 2023 Dec; 62(24):3585-3590. PubMed ID: 37081682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
    Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
    Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
    Battistella A; Partelli S; Andreasi V; Marinoni I; Palumbo D; Tacelli M; Lena MS; Muffatti F; Mushtaq J; Capurso G; Arcidiacono PG; De Cobelli F; Doglioni C; Perren A; Falconi M
    Surgery; 2022 Oct; 172(4):1236-1244. PubMed ID: 35953308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors.
    Morgan AD; Ramai D; Bandaru P; Crino SF; Facciorusso A
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1355-1358. PubMed ID: 37055906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
    Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
    Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinoma: CEUS characteristics are correlated with pathological findings and help predict early recurrence after resection.
    Wang L; Wang G; Wang P; Nie F
    J Clin Ultrasound; 2024; 52(3):230-240. PubMed ID: 38018362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing pancreatic solid serous cystadenomas from nonfunctional pancreatic neuroendocrine tumors by computed tomography: A propensity score analysis.
    Fang X; Jiang H; Cao K; Li J; Liu F; Wang L; Lu J; Shao C; Bian Y
    Medicine (Baltimore); 2022 Sep; 101(37):e30523. PubMed ID: 36123910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors.
    van Beek DJ; Verschuur AVD; Brosens LAA; Valk GD; Pieterman CRC; Vriens MR
    Surg Oncol Clin N Am; 2023 Apr; 32(2):343-371. PubMed ID: 36925190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
    Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
    Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single-center experience.
    Ren SJ; Wang X; Ke NW; Tan QQ; Yang F; Yao WQ; Tan CL; Liu XB
    Asian J Surg; 2023 Feb; 46(2):774-779. PubMed ID: 35850904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study.
    So H; Ko SW; Shin SH; Kim EH; Son J; Ha S; Song KB; Kim HJ; Kim MH; Park DH
    Gastrointest Endosc; 2023 Apr; 97(4):741-751.e1. PubMed ID: 36400239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.